Abstract
ObjectiveThe aim of this study was to evaluate over time circulating γδ T lymphocytes in melanomapatients in terms of frequency, effector functions, and relationship with clinical stage andevolution, by comparing preoperative values to those obtained at a mean follow-up of 36months or in the event of recurrence or disease progression, and to those of healthy controls.Also, we correlated the presence of tumor-infiltrating γδ T lymphocytes with clinicalevolution of melanoma.ResultsMean frequencies of circulating γδ T cells before and after melanoma removal were verysimilar and comparable to healthy subjects, but patients who progressed to stage III or IVshowed a significantly decreased frequency of circulating Vγ9Vδ2 T cells. The distributionof Vγ9Vδ2 memory and effector subsets was similar in healthy subjects and melanomapatients at diagnosis, but circulating γδ T cells of patients after melanoma removal had askewed terminally-differentiated effector memory phenotype. Highly suggestive of progressivedifferentiation toward a cytotoxic phenotype, Vγ9Vδ2T cells from patients at follow uphad increased cytotoxic potential and limited cytokine production capability, while the oppositepattern was detected in Vγ9Vδ2T cells from patients before melanoma removal.ConclusionsFollow-up data also showed that tumor infiltrating γδ T cells were significantly associatedwith lower mortality and relapse rates, suggesting that they may serve as a prognostic biomarker,for human melanoma
Lingua originale | English |
---|---|
Numero di pagine | 0 |
Rivista | PLoS One |
Volume | 11 |
Stato di pubblicazione | Published - 2016 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.1300.1300???
- ???subjectarea.asjc.1100.1100???
- ???subjectarea.asjc.1000???